You have 9 free searches left this month | for more free features.

Continual Reassessment Method

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

B Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, in Relapse Trial (Decreasing starting times for beginning

Not yet recruiting
  • B Acute Lymphoblastic Leukemia
  • Acute Lymphoblastic Leukemia, in Relapse
  • Decreasing starting times for beginning nivolumab (Time to Event Continual Reassessment Method (TITE-CRM) )
  • Nivolumab starting at day -1
  • (no location specified)
Apr 4, 2022

Oesophageal Adenocarcinoma, Squamous Cell Carcinoma, Solid Tumor Trial in United Kingdom (M6620, Cisplatin, Capecitabine)

Completed
  • Oesophageal Adenocarcinoma
  • +2 more
  • Cardiff, United Kingdom
  • +4 more
Apr 27, 2022

Pregnant Women Trial in Brussels Capital Region (HB Prilocaine 2% (varying dose), HB Prilocaine 2%, Sufentanil)

Completed
  • Pregnant Women
  • HB Prilocaine 2% (varying dose)
  • +3 more
  • Brussels Capital Region, Belgium
    University Hospital Saint-Pierre, Université Libre de Bruxelles
Apr 24, 2020

Post Operative Pain Trial in Seattle (Dose of 0.5% Ropivacaine)

Recruiting
  • Post Operative Pain
  • Dose of 0.5% Ropivacaine
  • Seattle, Washington
    Virginia Mason Medical Center
May 11, 2023

ive Dose 95 of Intrathecal Isobaric 2-chloroprocaine Based on

Completed
  • Knee Arthroscopy
  • Isobaric 2-chloroprocaine
  • Braine-l'Alleud,, Belgium
    Braine-l'Alleud Hospital
Oct 4, 2019

Medication Adherence Trial in Manhasset (5 Behavioral Change Techniques)

Recruiting
  • Medication Adherence
  • 5 Behavioral Change Techniques
  • Manhasset, New York
    Northwell Health
Jul 12, 2023

Medication Adherence Trial in New York (5 Behavioral Change Techniques)

Recruiting
  • Medication Adherence
  • 5 Behavioral Change Techniques
  • New York, New York
    Institute of Health System Science
Sep 6, 2022

Non Small Cell Lung Cancer Trial in Canada (SBRT)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • SBRT
  • Vancouver, British Columbia, Canada
  • +6 more
Apr 12, 2022

Insufficient Physical Activity Trial in New York (5 Behavioral Change Techniques)

Recruiting
  • Insufficient Physical Activity
  • 5 Behavioral Change Techniques
  • New York, New York
    Institute of Health System Science
May 17, 2022

Lung Cancer Trial in Heidelberg (Stereotactic body radiotherapy (SBRT))

Recruiting
  • Lung Cancer
  • Stereotactic body radiotherapy (SBRT)
  • Heidelberg, Germany
    University Hospital of Heidelberg, Radiation Oncology
Nov 2, 2022

Locally Advanced NSCLC Trial in Edinburgh, London, Oxford (Atovaquone Oral Suspension, Standard of care chemo, Standard of care

Recruiting
  • Locally Advanced Non-Small Cell Lung Cancer
  • Atovaquone Oral Suspension
  • +2 more
  • Edinburgh, United Kingdom
  • +1 more
Dec 21, 2021

Hematological Malignancies Trial in Durham (fostamatinib)

Active, not recruiting
  • Hematological Malignancies
  • Durham, North Carolina
    Duke University of Medicine
Jul 14, 2022

Acute Myeloid Leukemia (AML) Trial in Nantes (Tocilizumab)

Active, not recruiting
  • Acute Myeloid Leukemia (AML)
  • Nantes, France
    CHU of Nantes
Dec 16, 2022

Neonatal Seizure, Neonatal Encephalopathy, Hypoxic-Ischemic Encephalopathy Trial in San Diego (Levetiracetam Injection,

Not yet recruiting
  • Neonatal Seizure
  • +3 more
  • Levetiracetam Injection
  • Phenobarbital Sodium Injection
  • San Diego, California
    University of California, San Diego
Nov 6, 2022

Breast Cancer Trial (Reimbursement)

Not yet recruiting
  • Breast Cancer
  • Reimbursement
  • (no location specified)
May 22, 2023

Adult Patients With Adverse Risk Acute Myeloblastic Leukemia Trial (Darzalex)

Not yet recruiting
  • Adult Patients With Adverse Risk Acute Myeloblastic Leukemia
  • (no location specified)
Feb 27, 2023

Laceration Repair Trial in London (Dexmedetomidine)

Completed
  • Laceration Repair
  • London, Ontario, Canada
    London Health Sciences Centre
Apr 5, 2022

Acute Myeloid Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Cord Blood Transplant Recipient Trial in Houston

Recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • Recombinant Interleukin-7
  • Houston, Texas
    M D Anderson Cancer Center
Jan 26, 2023

Head Neck Cancer Trial in Milwaukee (46 Gy Radiation Therapy, 40 Gy Radiation Therapy, 35 Gy Radiation Therapy)

Not yet recruiting
  • Head and Neck Cancer
  • 46 Gy Radiation Therapy
  • +2 more
  • Milwaukee, Wisconsin
    Froedtert Hospital and the Medical College of Wisconsin
Sep 9, 2022

Advanced Adult Hepatocellular Carcinoma Trial in Chicago, Ann Arbor, Dallas (Cabozantinib)

Recruiting
  • Advanced Adult Hepatocellular Carcinoma
  • Chicago, Illinois
  • +3 more
Aug 15, 2022

Recurrent Glioblastoma Trial (Niraparib, Re-irradiation (re-RT))

Not yet recruiting
  • Recurrent Glioblastoma
  • (no location specified)
Dec 23, 2022

Recurrent Endometrial Cancer Trial in France (Olaparib, metformin, metronomic cyclophosphamide)

Completed
  • Recurrent Endometrial Cancer
  • Caen, France
  • +5 more
Dec 6, 2021

Pancreatic Carcinoma Non-resectable Trial in Ottawa (CyberKnife® Stereotactic Body Radiotherapy(SBRT)Boost)

Terminated
  • Pancreatic Carcinoma Non-resectable
  • CyberKnife® Stereotactic Body Radiotherapy(SBRT)Boost
  • Ottawa, Ontario, Canada
    The Ottawa Hospital Cancer Centre
Apr 13, 2020

Chronic Lung Disease of Prematurity, Respiratory Distress Syndrome in Premature Infant, Bronchopulmonary Dysplasia Trial

Not yet recruiting
  • Chronic Lung Disease of Prematurity
  • +2 more
  • Recombinant fragment of human surfactant protein D (rfhSP-D)
  • (no location specified)
Jun 6, 2023